{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:49:51Z","timestamp":1790192991764,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jdiacomp.2025.109002","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T01:10:42Z","timestamp":1742692242000},"page":"109002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The NGAL as a prognostic biomarker of kidney injury in children and adolescents with type 1 diabetes mellitus: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Nikolaos","family":"Gkiourtzis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Stoimeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Michou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Cheirakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Moutafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristeidis","family":"Christakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agni","family":"Glava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Panagopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tsigaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assimina","family":"Galli-Tsinopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Christoforidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Tramma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2025.109002_bb0005","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/biom13040633","article-title":"Novel biomarkers of diabetic kidney disease","volume":"13","author":"Rico-Fontalvo","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0010","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/pedi.13444","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: microvascular and macrovascular complications in children and adolescents with diabetes","volume":"23","author":"Bjornstad","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2215\/CJN.03530708","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease","volume":"4","author":"Bolignano","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/4647685","article-title":"Urinary markers of tubular injury in early diabetic nephropathy","volume":"2016","author":"Fiseha","year":"2016","journal-title":"International Journal of Nephrology"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0025","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.ekir.2022.03.033","article-title":"Biomarkers of kidney tubule disease and risk of end-stage kidney disease in persons with diabetes and CKD","volume":"7","author":"Amatruda","year":"2022","journal-title":"Kidney International Reports"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0030","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.ekir.2021.01.012","article-title":"Evaluation of urinary biomarkers of proximal tubular injury, inflammation, and fibrosis in patients with albuminuric and nonalbuminuric diabetic kidney disease","volume":"6","author":"Phanish","year":"2021","journal-title":"Kidney International Reports"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7659243","article-title":"Markers of glomerular and tubular damage in the early stage of kidney disease in type 2 diabetic patients","volume":"2018","author":"\u017by\u0142ka","year":"2018","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000507858","article-title":"Significance of neutrophil gelatinase-associated lipocalin as a biomarker for the diagnosis of diabetic kidney disease: a systematic review and meta-analysis","volume":"45","author":"He","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.62347\/FVBS3902","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a potential early biomarker for diabetic nephropathy: a meta-analysis","volume":"15","author":"Prashant","year":"2024","journal-title":"Int J Biochem Mol Biol"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/0886022X.2019.1619581","article-title":"Diagnostic value of neutrophil gelatinase-associated lipocalin in diabetic nephropathy: a meta-analysis","volume":"41","author":"Chen","year":"2019","journal-title":"Ren Fail"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1373\/jalm.2018.028530","article-title":"Diagnostic accuracy of neutrophil gelatinase-associated lipocalin for predicting early diabetic nephropathy in patients with type 1 and type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"4","author":"Kapoula","year":"2019","journal-title":"The Journal of Applied Laboratory Medicine"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0060","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"n71","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0075","unstructured":"Wells GA, Shea B, O'Connell D, Peterson JE, Welch V, Losos M, et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000."},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Mental Health"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0095","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/sim.1221","article-title":"A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials","volume":"21","author":"Baujat","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0100","article-title":"Network meta-analysis: application and practice using R software","volume":"41","author":"Shim","year":"2019","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jclinepi.2008.05.011","article-title":"Meta-analysis methods for diagnostic accuracy","volume":"61","author":"Begg","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/children8050417","article-title":"Poor glycemic control can increase the plasma kidney injury molecule-1 concentration in normoalbuminuric children and adolescents with diabetes mellitus","volume":"8","author":"Ahn","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0115","first-page":"29","article-title":"Value of the intrarenal arterial resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients","author":"Abd El Dayem","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0120","first-page":"25","article-title":"Evaluation of neutrophil gelatinase-associated lipocalin in normoalbuminuric normotensive type 1 diabetic adolescents","author":"Demir","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0125","first-page":"126","article-title":"Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria","volume":"9","author":"Hafez","year":"2015","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0130","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1007\/s00467-022-05487-4","article-title":"Relationship between biomarkers of tubular injury and intrarenal hemodynamic dysfunction in youth with type 1 diabetes","volume":"37","author":"Johnson","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.11613\/BM.2024.020709","article-title":"Is the urinary neutrophil gelatinase-associated lipocalin concentration in children and adolescents with type 1 diabetes mellitus different from that in healthy children?","volume":"34","author":"Uni\u0107","year":"2024","journal-title":"Biochem Med (Online)"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0140","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40200-024-01419-1","article-title":"Cystatin C as an adjunct to HbA1c may prove useful in predicting the development of diabetic complications in children and adolescents with type 1 diabetes","volume":"23","author":"Nilsson","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0145","article-title":"NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up","author":"Papadopoulou-Marketou","year":"2014","journal-title":"HJ"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/7526919","article-title":"NGAL as an early predictive marker of diabetic nephropathy in children and young adults with type 1 diabetes mellitus","volume":"2017","author":"Papadopoulou-Marketou","year":"2017","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0155","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/pedi.13259","article-title":"Tubular injury in diabetic ketoacidosis: results from the diabetic kidney alarm study","volume":"22","author":"Piani","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0160","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1515\/jpem-2024-0172","article-title":"Urinary biomarkers NG AL and beta-2 microglobulin in children with type 1 diabetes mellitus","volume":"37","author":"Sachan","year":"2024","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5603\/EP.2014.0067","article-title":"Lipokaina zwi\u0105zana z \u017celatynaz\u0105 neutrofilii i katepsyna L jako wczesne markery uszkodzenia nerek u dzieci z cukrzyc\u0105 typu 1","volume":"65","author":"So\u0142tysiak","year":"2015","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0170","first-page":"76","article-title":"Early kidney damage in diabetic adolescents with increased blood pressure and glomerular hyperfiltration","author":"Soltysiak","year":"2024","journal-title":"Minerva Pediatr"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0175","first-page":"29","article-title":"Kidney injury molecule-1 and neutrophil gelatinase associated lipocalin in normoalbuminuric diabetic children","author":"Ucakturk","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.654269","article-title":"Urinary extracellular vesicles as a source of NGAL for diabetic kidney disease evaluation in children and adolescents with type 1 diabetes mellitus","volume":"12","author":"Ugarte","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0185","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4274\/jcrpe.2002","article-title":"Neutrophil gelatinase-associated lipocalin as an early sign of diabetic kidney injury in children","volume":"7","author":"Y\u00fcr\u00fck Y\u0131ld\u0131r\u0131m","year":"2015","journal-title":"Jcrpe"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0190","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00467-010-1443-z","article-title":"Normal-range albuminuria does not exclude nephropathy in diabetic children","volume":"25","author":"Zachwieja","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0195","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/pedi.13454","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents","volume":"23","author":"Libman","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0200","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/0886022X.2019.1617736","article-title":"Urine NGAL as an early biomarker for diabetic kidney disease: accumulated evidence from observational studies","volume":"41","author":"Tang","year":"2019","journal-title":"Ren Fail"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0205","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","author":"De Boer","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10157-020-01881-0","article-title":"Nonproteinuric diabetic kidney disease","volume":"24","author":"Yamanouchi","year":"2020","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12902-022-01052-0","article-title":"Diagnostic value of serum cystatin C for diabetic nephropathy: a meta-analysis","volume":"22","author":"Liao","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0220","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.ki.5002165","article-title":"Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage","volume":"71","author":"Mori","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0225","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.3390\/ijms241310470","article-title":"The review of current knowledge on neutrophil gelatinase-associated Lipocalin (NGAL)","volume":"24","author":"Romejko","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0230","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1515\/cclm-2012-0540","article-title":"Reference values for urinary neutrophil gelatinase-associated lipocalin (NGAL) in pediatric age measured with a fully automated chemiluminescent platform","volume":"51","author":"Cangemi","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jdiacomp.2025.109002_bb0235","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2217\/bmm.14.36","article-title":"Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children","volume":"8","author":"McWilliam","year":"2014","journal-title":"Biomark Med"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725000558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872725000558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T15:51:32Z","timestamp":1744386692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872725000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1056872725000558"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109002","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The NGAL as a prognostic biomarker of kidney injury in children and adolescents with type 1 diabetes mellitus: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109002"}}